CREBBP and diffuse large B-cell lymphoma: Importantly, two GCB-like DLBCL cell lines that were highly sensitive to EP300 knockout harboured mutations (WSUDLCL2) or copy number variation (CNV) loss (SUDHL5) in CREBBP (Fig. 5B and Supplementary Table S6).